| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Department of Neurology,* Heinrich-Heine-University, Düsseldorf, Germany; the Department of Neurology,
Julius-Maximilians-University, Würzburg, Germany; the Department of Neurology,
University of Tübingen, Tübingen, Germany; and the Division of Neuroimmunology,
Brain Research Institute, University of Vienna, Vienna, Austria
| Abstract |
|---|
|
|
|---|
In rats, distinct disease variants of EAE can be distinguished.5 MBP-induced EAE in Lewis rats as the classical model of CD4+ helper-cell-mediated CNS inflammation is characterized by strong infiltration of T cells and macrophages into the CNS but an almost complete preservation of myelin and axons. Accordingly, the disease takes a self-limiting monophasic course leading to complete recovery of even severely affected animals. Contrastingly, immunization of DA, BN, and certain MHC-congenic rat strains with a recombinant aminoterminal fragment of myelin oligodendrocyte glycoprotein (MOG) leads to chronic progressive or relapsing disease with substantial permanent disability.6,7 Detailed morphological studies of MOG-EAE revealed that this model mimics key features of MS-like neuropathology such as demyelination, glial scarring, and axonal damage.6 The relative extent of these histopathological findings in different rat strains is genetically determined by factors both within and outside the MHC.7,8
So far, the specific role of CD8+ cells for lesion pathogenesis in MOG-EAE is unknown. In the present study, we performed an immunohistochemical analysis of CD8 expression in chronic demyelinating MOG-EAE in comparison to MBP-induced disease as a model of nondemyelinating CNS inflammation. We report the unexpected finding that the majority of CD8 in MOG-induced EAE is not expressed on T cells but instead on a subset of lesion-associated macrophages.
| Materials and Methods |
|---|
|
|
|---|
All rat experiments were performed in accordance with institutional guidelines. MOG-EAE was induced in 10- to 14-week-old female BN (RT1n), DA (RT1av1), and LEW.1N (RT1n) rats by active immunization with the recombinant MOG protein corresponding to the N-terminal sequence of rat MOG (amino acids 1125) as described previously.6,7 For immunohistochemical analysis, rats were perfused with 4% paraformaldehyde between day 27 and 33 (BN, DA) and on day 61 (LEW.1N) after immunization corresponding to maximum disease severity in the chronic disease stage. MBP-EAE was induced in 8-week-old female Lewis rats (Charles River Laboratories, Wilmington, MA) either by active immunization with an encephalitogenic peptide (25 µg per rat) comprising amino acids 6886 of guinea pig myelin basic protein (MBP)9 or passive transfer of 106 MBP-specific T-cell line cells.10 Rats were perfused at the peak of clinical disease severity (day 13 after active immunization, day 6 to 7 after T-cell transfer). Spinal cords were dissected out and routinely embedded into paraffin.
Neuropathological Analysis and Immunohistochemistry
To assess inflammation, demyelination, and axonal pathology paraffin sections were stained with hematoxylin and eosin, luxol fast blue, and Bielschowsky silver impregnation, respectively.6
For immunohistochemistry, serial 5-µm paraffin sections were incubated with the following primary antibodies: mAb ED1 against the macrophage-specific CD68 antigen (1:2000; Serotec, Oxford, UK), mAbs Ox-8 (1:1000; Serotec), or 1511C5 (1:1000; Hycult Biotechnology, Uden, The Netherlands) against the CD8
chain, and mAb W3/13 against the pan-T cell marker CD43 (1:500; Serotec). Mouse mAb A1122 (IgG1) against keyhole limpet hemocyanin (1:1000; PharMingen, Palo Alto, CA) was used as an isotype-matched negative control antibody. Bound antibody was detected using biotinylated horse anti-mouse IgG and the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) with diaminobenzidine as substrate according to the manufacturers protocol.
Double-Labeling Immunofluorescence and Confocal Microscopy
For double-labeling immunofluorescence with two mouse mAbs on the same tissue section we used a sequential staining procedure which is based on the detection of one of the primary antibodies by high-sensitivity tyramide signal amplification.11 In a first step, either mAb Ox-8 or the A1122 isotype matched negative control mAb were applied at 1:10,000 dilution, followed by donkey anti-mouse horseradish peroxidase (Jackson Immunoresearch, West Grove, PA) at 1:500 dilution and the TSA Plus Fluorescein System (PerkinElmer Life Sciences, Boston, MA) according to the manufacturers protocol. In a second staining round, either mAb ED1 as a macrophage marker (1:500) or mAb 156A1 as a pan-T cell marker (1:200; Hycult Biotechnology) were detected by donkey anti-mouse Texas Red (1:100; Jackson Immunoresearch). Sections were mounted with Vectashield mounting medium (Vector Laboratories) and analyzed using a Leica TCS-NT confocal laser scanning system with an argon-krypton laser on a Leica DM IRB inverted microscope. Images were acquired from two channels at 488 nm and 568 nm wavelength. To analyze the localization of different antigens in double-stained samples, images obtained from the appropriate excitation wavelength were collected and merged.
| Results |
|---|
|
|
|---|
We first studied the distribution and morphology of CD8+ cells in the various models of rat EAE by conventional immunoperoxidase staining with the rat CD8
-specific mAb Ox-8. In nondemyelinating MBP-EAE, CD8+ cells were found with a relatively low frequency and mainly exhibited the morphology of small lymphocyte-like cells which were located in the immediate surroundings of inflamed vessels (Figure 1A)
. In contrast to MBP-EAE, immunization of DA, BN, or LEW.1N rats with MOG leads to severe demyelination and axonal injury.6
In these models, much stronger expression of CD8 was found. Figure 1, B to E
, shows typical findings from a DA rat with a large lesion in the dorsal column of the spinal cord. CD8+ cells were mainly located in the parenchyma of the demyelinating lesion. At higher magnification, some smaller lymphocyte-like CD8+ cells were observed in a perivascular position (arrowheads in Figure 1C
). However, the vast majority of CD8+ cells were located in the demyelinated parenchyma and had the morphology of large phagocyte-like cells (arrows in Figure 1, C and E
). Similar findings were obtained in BN and LEW.1N rats. Control experiments using mAb 1511C5 as an alternative rat CD8
-specific mouse mAb yielded identical staining patterns. Conversely, omission of the primary antibodies or their replacement by isotype-matched control mAb A1122 led to a complete disappearance of immunostaining.
|
To study the distribution of CD8+ cells in MOG-EAE in more detail we stained serial sections with the cell lineage markers ED1 for phagocytic macrophages and W3/13 for pan-T cells (Figure 2)
. These studies were done in the LEW.1N strain characterized by particularily strong CD8 expression. Figure 2
is taken from a large demyelinating lesion in the lumbothoracal spinal cord. CD8+ cell recruitment was most pronounced in central necrotic (dashed line in Figure 2E
) and severely demyelinated (dashed line in Figure 2F
) lesion areas. Contrastingly, perivascular cuffs (arrows in Figure 2, C and D
) and submeningeal areas (dashed line in in Figure 2C
) were densely infiltrated by ED1+ macrophages but largely spared from CD8+ cell infiltration (Figure 2, E and F)
. In fiber tracts undergoing secondary Wallerian-like degeneration (dashed line in Figure 2D
) CD8 expression was also much weaker. This was particularily evident in the most rostral part of the lesion (Figure 3)
where Wallerian-like degenerative changes were predominant and T-cell infiltration absent (Figure 3C)
. At this level, CD8 expression was greatly reduced (Figure 3B)
despite strong expression of the ED1 antigen (Figure 3A)
. Thus, along the rostrocaudal extension of the lesion CD8+ cell recruitment was overall associated with T-cell infiltration as an indicator of ongoing immune-mediated tissue destruction. However, at a given lesion level, both the morphology and spatial distribution of T cells (Figure 2, G and H)
was clearly distinct from that of CD8+ cells (Figure 2, E and F)
.
|
|
To clarify the cellular localization of the CD8 antigen in the lesions of MOG-EAE we performed double-labeling immunofluorescent staining in combination with confocal microscopy (Figure 4)
. Since these studies relied on the sequential application of two mouse monoclonal antibodies on the same tissue section we used a special double-staining protocol in which the CD8 antigen was detected by tyramide signal amplification.11
Preliminary experiments were performed to exclude undesired cross-reactions between secondary detection antibodies (not shown).11
|
| Discussion |
|---|
|
|
|---|
ß heterodimer.12,15,21,22
Functionally, signaling via the CD8 molecule leads to the release of inflammatory mediators such as nitric oxide and tumor necrosis factor-
from cultured alveolar macrophages.21,22
Thus, expression of the CD8 antigen is more promiscuous than previously thought and may mediate important functions in inflammatory macrophage activation. In our present study we show that in demyelinating spinal cord lesions occurring during MOG-EAE in rats the vast majority of CD8 immunoreactivity is expressed on a subset of lesion-associated phagocytes. CD8+ T cells were overall rare and mostly restricted to the perivascular space. CD8+ phagocytes coexpressed the phagocyte-specific ED1 marker and in most cases exhibited the morphology of round, presumably blood-derived macrophages. However, we additionally found some ED1+/CD8+ cells with a ramified morphology typical of activated resident microglia. This is in line with previous studies showing CD8+ microglia-like cells in rat models of cerebral ischemia14 and malignant glioma.24 Thus, it seems likely that both hematogenous macrophages and resident microglia contribute to the population of CD8+ phagocytes.
In contrast to MOG-EAE, essentially all macrophages infiltrating inflammatory lesions of MBP-EAE were CD8-. Thus, when comparing the various EAE models characterized by a different extent of tissue destruction, the appearance of CD8+ phagocytes was specifically associated with the development of demyelination and axonal damage characteristic of MOG-EAE whereas a purely inflammatory pathology without structural tissue damage as seen in MBP-EAE did not induce the CD8+ phagocyte phenotype. A similar association was found at the level of the individual lesion in MOG-EAE since most macrophages in perivascular cuffs were CD8- whereas those in demyelinated lesion areas were CD8+. Furthermore, ED1+ macrophages in fiber tracts undergoing secondary Wallerian-type degeneration were CD8- which is in line with our previous findings in experimental axotomy models.15 Taken together, these data demonstrate significant heterogeneity of lesion-associated phagocytes in CNS autoimmunity and suggest a specific role of CD8+ macrophages/microglia in the pathogenesis of immune-mediated tissue damage in MOG-EAE.
Interestingly, a similar association between CD8+ phagocyte recruitment and the specific type of tissue damage can be delineated in focal brain ischemia.12-14 Transient occlusion of the middle cerebral artery leads to the development of heterogenous cerebral infarctions in which the densely ischemic infarct core undergoes pannecrotic tissue damage comprising both neurons and glia whereas at the lesion periphery selective neuronal death with relative preservation of glia ensues.25 In this model, the infiltration of CD8+ macrophages is restricted to the severely damaged infarct core whereas in peripheral lesion areas microglial induction of CD4 but not CD8 antigen can be seen.14 In addition, secondarily degenerating subcortical fiber tracts are likewise spared form CD8+ phagocyte infiltration.13 Under functional aspects, it remains an open question if CD8+ phagocytes actively contribute to the process of tissue destruction or are part of a secondary wound healing response concerned with extracellular matrix remodeling, induction of gliosis, and the resulting demarcation of the lesion. In cerebral ischemia, the recruitment of CD8+ phagocytes occurs slightly delayed and is correlated with the expression of anti-inflammatory and growth-promoting factors rather than pro-inflammatory cytokines. The precise sequence of pro- versus anti-inflammatory cytokine expression in MOG-EAE is currently unknown.
Dendritic cells (DCs) are recruited into inflammatory CNS lesions26,27 and can express ED1 and/or CD8 antigens.28 Therefore, we cannot rule out the possibility that DCs contribute to the population of CD8+ cells in MOG-EAE lesions. A more comprehensive analysis of DCs in MOG-EAE was not possible in our study since there is currently no rat pan-DC marker for use in paraffin-embedded tissue. However, the specific phenotype of the CD8+ cells identified in MOG-EAE and other lesion paradigms12,15 and their association with a chronic destructive lesion type characterized by little T-cell infiltration seems to be compatible with a phagocytic rather than dendritic cell lineage.
CD8+ cells constitute a considerable component of the inflammatory infiltrate in demyelinating MS lesions and are significantly correlated with the extent of demyelination and axonal injury.1,3,29
However, based on single-color immunohistochemistry, CD8 immunoreactivity in MS lesions appears to be mainly associated with small lymphocyte-like cells.29
The interpretation of these results is complicated by the fact that the currently available CD8-specific antibodies exhibit considerable epitope fine specificity. In the rat, CD8+ macrophages can be detected using mAb Ox-8 directed against the hinge region of the CD8
chain,12,15,21
mAbs R110B5 and 1511C5 against yet undefined epitopes in the CD8
chain,12,15,30
and mAb 341 against the CD8ß chain.12,15,19-21
By contrast, mAb G-28 specific for the IgV-like domain of CD8
recognizes T lymphocytes but not macrophages.21,23
Most human CD8-specific mAbs, on the other hand, have been raised against C-terminal peptide fragments of the CD8
molecule whereas no hinge-region specific antibodies are available. Thus, it remains an open question if CD8+ macrophages likewise exist in humans. Of note, considerable species specifity has been shown with respect to the CD4 antigen which is expressed on human and rat, but not mouse macrophages.31
It is therefore conceivable that the CD8 antigen has its value as a marker for specific subsets of lesion-associated phagocytes in the rat whereas corresponding marker antigens for these cells in other species remain to be identified.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by Deutsche Forschungsgemeinschaft, Ja 690/41 (SPP 1029).
Accepted for publication June 27, 2003.
| References |
|---|
|
|
|---|
and CD8ß induce nitric oxide production and associated killing of the parasite Leishmania major. J Immunol 1998, 160:6004-6011This article has been cited by other articles:
![]() |
D. Merkler, T. Ernsting, M. Kerschensteiner, W. Bruck, and C. Stadelmann A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination Brain, August 1, 2006; 129(8): 1972 - 1983. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |